Ownership of New Inventions. The Employee agrees that all Inventions:
Ownership of New Inventions. 4.1.1 The Client shall acquire no rights to new enhancements, translations, re-writings, revisions, updates, modifications, or improvements made by Company/Client in connection with the Payment Gateway (hereinafter — “the New Inventions”) which shall be considered as an integral part of the Payment Gateway, including but not limited to Acquirer integration software, from the moment of their creation unless parties agree to treat it differently and sign their intentions in the separate Agreement or Addendum to this contract.
Ownership of New Inventions. During the Agreement Term, except as otherwise provided in and subject to the terms of this Agreement, the following shall be applicable:
Ownership of New Inventions. During the Term, except as otherwise provided in and subject to the terms of this Agreement,
Ownership of New Inventions. 10.2.1 Inventorship of any invention that is developed, discovered or made by a Party, solely or jointly with the other Party (as applicable, the "Inventor") pursuant to work conducted under this Agreement (an "Invention") shall be determined in accordance with United States laws of inventorship, subject only to the license rights granted under this Agreement. Each Party shall promptly notify the other Party if it determines that an Invention has been made. EndoChem shall obtain from each of its employees, contractors, representatives and agents a written obligation to assign to EndoChem all right, title and interest in and to all Inventions. The Inventor of such Invention shall be deemed the owner thereof.
Ownership of New Inventions. The parties agree that any and all New Inventions (whether or not they are patentable, copyrightable or otherwise protected under existing or future intellectual property rights) shall be entirely and exclusively owned by VUSA and are hereby entirely and irrevocably assigned (including all patents and copyrights) by ABC and the PIBCs to VUSA without reservation or further obligation or consideration that in any way relate to or arise out (i) of the use or access to the Confidential Information (specifically including but not limited to the Specifications and means of manufacturing human source leukocytes), trade secret or patent (including any unissued patent applications) or (ii) to any VUSA or Viragen current or contemplated product. VUSA will have the sole right to determine the treatment of such New Inventions, including the right to keep it as trade secrets, to file and execute patent applications on it, to use and disclose it without prior patent application, to file registrations for copyright or trade or other marks in its own name, or to follow any other procedure that VUSA deems appropriate. VUSA shall have the right to a worldwide, sublicenseable and exclusive, or at its election non-exclusive, license on commercially reasonable terms to any or all rights ABC or the PIBCs may have in all other New Inventions.
Ownership of New Inventions. Any new invention, development or discovery relating to the Field or New Prostate Markers for the Field conceived, made or reduced to practice by either party as part of the Collaboration, the FDA Submission Plan or with the use of Materials of the other party (each a “New Invention”) shall be promptly disclosed in writing to the other party. Each party shall retain sole ownership in each Invention made solely by that party.
Ownership of New Inventions. All rights to New Inventions made solely by GLADSTONE's employees and agents and arising from research conducted under this Agreement shall belong to GLADSTONE, subject to the rights of The Regents pursuant to the GLADSTONE/Regents Agreement (GLADSTONE and The Regents are hereinafter referred to as "GLADSTONE/Regents"). CNPI shall cause its employees and agents to assign all rights to New Inventions to CNPI. All rights to New Inventions made jointly by GLADSTONE's employees or agents with one or more employees or agents of CNPI and arising from research conducted under this Agreement shall belong jointly to GLADSTONE/Regents and CNPI. CNPI shall be granted rights under the Option/License Agreement to GLADSTONE's and The Regents' interest in New Inventions in the Field in accordance with the terms thereof and CNPI shall be granted rights under The Regents' interest in New Inventions outside the Field in accordance with Section 6.4 below. The Regents agrees to assert rights to the Invention (as defined in the Option/License Agreement) and New Inventions both in and outside of the Field.
Ownership of New Inventions. (a) All materials, documents, information, programs and Intellectual Property provided to Xxxxxx by Client or on behalf of Client in connection with the performance of the Services shall be the exclusive property of Client. Xxxxxx will have no rights of ownership, registration or independent use with regard to (i) the Specifications provided by Client, (ii) any manufacturing processes or technology provided by Client to Xxxxxx for use in the manufacture of the Client Product, or (iii) any other Client Existing Intellectual Property.
Ownership of New Inventions. 6.2.1. With the exception of Out of Scope Inventions as set forth in Section 3.5, ownership of new inventions shall be determined by inventorship under principles of U.S. patent law. In the event that the Parties are unable to reach agreement as to inventorship, the Parties shall jointly engage an independent patent counsel to determine inventorship, the cost of which shall be split between evenly between the Parties. The Parties hereby agree that they shall be bound by the inventorship determinations made by the independent counsel.
